Alcon AG
SIX:ALC

Watchlist Manager
Alcon AG Logo
Alcon AG
SIX:ALC
Watchlist
Price: 69.5 CHF -0.8% Market Closed
Market Cap: 34.7B CHF
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one ALC stock under the Base Case scenario is 93.96 CHF. Compared to the current market price of 69.5 CHF, Alcon AG is Undervalued by 26%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALC Relative Value
Base Case
93.96 CHF
Undervaluation 26%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4.2
P/S
P/S
Price to Sales
4.2
vs History
60
vs Industry
27
Median 3Y
4.3
Median 5Y
4.5
Industry
2.2
Forward
4
More Details
37.5
P/E
P/E
Price to Earnings
37.5
vs History
73
vs Industry
11
Median 3Y
50.5
Median 5Y
44.7
Industry
21.9
Forward
25.5
More Details
19.8
P/OCF
P/OCF
Price to OCF
19.8
vs History
98
vs Industry
16
Median 3Y
26.9
Median 5Y
28.2
Industry
14
More Details
35.3
P/FCFE
P/FCFE
Price to FCFE
35.3
vs History
80
vs Industry
9
Median 3Y
52
Median 5Y
51
Industry
19.7
More Details
1.9
P/B
P/B
Price to Book Value
1.9
vs History
46
vs Industry
39
Median 3Y
2
Median 5Y
1.9
Industry
2.1
More Details
4.6
EV/S
EV/S
Enterprise Value to Sales
4.6
vs History
60
vs Industry
24
Median 3Y
4.7
Median 5Y
4.8
Industry
2.3
Forward
4.3
More Details
8.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
8.5
vs History
66
vs Industry
24
Median 3Y
8.6
Median 5Y
8.9
Industry
4.8
More Details
17.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
17.3
vs History
85
vs Industry
18
Median 3Y
18.8
Median 5Y
19.1
Industry
11.5
Forward
16.2
More Details
32.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
32.7
vs History
80
vs Industry
12
Median 3Y
38.2
Median 5Y
39.3
Industry
15.7
Forward
21.6
More Details
21.5
EV/OCF
EV/OCF
Enterprise Value to OCF
21.5
vs History
96
vs Industry
16
Median 3Y
29.6
Median 5Y
30.8
Industry
14
More Details
31.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
31.3
vs History
76
vs Industry
12
Median 3Y
40.1
Median 5Y
77.2
Industry
17.4
More Details
1.6
EV/IC
EV/IC
Enterprise Value to IC
1.6
vs History
39
vs Industry
41
Median 3Y
1.6
Median 5Y
1.5
Industry
1.8
More Details

Multiples Across Competitors

ALC Competitors Multiples
Alcon AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CH
Alcon AG
SIX:ALC
34.4B CHF 4.2 37.5 17.3 32.7
JP
Hoya Corp
TSE:7741
5.9T JPY 6.8 29.1 17.9 21.3
DK
Coloplast A/S
CSE:COLO B
135.8B DKK 4.9 29.9 17.3 20.4
US
Align Technology Inc
NASDAQ:ALGN
13.2B USD 3.3 32.1 15.3 18.8
UK
ConvaTec Group PLC
LSE:CTEC
5.8B GBP 3.4 40.7 209.9 343.3
CH
Ypsomed Holding AG
SIX:YPSN
5.5B CHF 7.3 62.6 30.1 51.5
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
45.9B CNY 13 32.9 28.4 28.4
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.5B USD 4 44.9 20.7 36.2
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.5B USD 3.6 21.5 9.9 11.3
KR
HLB Inc
KOSDAQ:028300
6.6T KRW 88.4 -35 -62.1 -58.7
JP
Asahi Intecc Co Ltd
TSE:7747
613.9B JPY 5.2 58.3 14.8 20.2
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CH
Alcon AG
SIX:ALC
Average EV/EBITDA: 38.2
17.3
10%
1.7
JP
Hoya Corp
TSE:7741
17.9
9%
2
DK
Coloplast A/S
CSE:COLO B
17.3
9%
1.9
US
Align Technology Inc
NASDAQ:ALGN
15.3
15%
1
UK
ConvaTec Group PLC
LSE:CTEC
209.9
11%
19.1
CH
Ypsomed Holding AG
SIX:YPSN
30.1
31%
1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
28.4
18%
1.6
US
Merit Medical Systems Inc
NASDAQ:MMSI
20.7
12%
1.7
US
Lantheus Holdings Inc
NASDAQ:LNTH
9.9
21%
0.5
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -62.1 N/A N/A
JP
A
Asahi Intecc Co Ltd
TSE:7747
14.8
11%
1.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CH
Alcon AG
SIX:ALC
Average EV/EBIT: 58.4
32.7
25%
1.3
JP
Hoya Corp
TSE:7741
21.3
N/A N/A
DK
Coloplast A/S
CSE:COLO B
20.4
9%
2.3
US
Align Technology Inc
NASDAQ:ALGN
18.8
17%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
343.3
22%
15.6
CH
Ypsomed Holding AG
SIX:YPSN
51.5
40%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
28.4
16%
1.8
US
Merit Medical Systems Inc
NASDAQ:MMSI
36.2
28%
1.3
US
Lantheus Holdings Inc
NASDAQ:LNTH
11.3
22%
0.5
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -58.7 N/A N/A
JP
A
Asahi Intecc Co Ltd
TSE:7747
20.2
N/A N/A

See Also

Summary
ALC intrinsic value, competitors valuation, and company profile.
DCF Valuation
ALC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ALC stock valuation using valuation multiples.
Wall Street Estimates
ALC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ALC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 262,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.